Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

8,917 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 8,917 results

Not applicableLooking for participantsNCT05326334
What this trial is testing

THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)

Who this might be right for
Glioblastoma, IDH-wildtype
Ottawa Hospital Research Institute 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04969887
What this trial is testing

Combination Immunotherapy in Rare Cancers Under InvesTigation

Who this might be right for
Advanced Biliary Tract CancerNeuroendocrine TumorsFemale Reproductive System Neoplasm+1 more
Olivia Newton-John Cancer Research Institute 240
Testing effectiveness (Phase 2)UnknownNCT05133349
What this trial is testing

A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial

Who this might be right for
Advanced or Metastatic Paraganglioma/ Pheochromocytoma
Nanjing First Hospital, Nanjing Medical University 20
Testing effectiveness (Phase 2)UnknownNCT03941626
What this trial is testing

Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies

Who this might be right for
Esophagus CancerHepatomaGlioma+1 more
Shenzhen BinDeBio Ltd. 50
Early research (Phase 1)Study completedNCT03229278
What this trial is testing

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmMetastatic Melanoma+26 more
Rutgers, The State University of New Jersey 14
Not applicableLooking for participantsNCT07251335
What this trial is testing

Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active Search and Prevention of Occupational Diseases Based on Recent INAIL Criteria

Who this might be right for
Skin MelanomaCutaneous Melanoma
University of Modena and Reggio Emilia 300
Testing effectiveness (Phase 2)Study completedNCT00026143
What this trial is testing

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07337447
What this trial is testing

Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01)

Who this might be right for
Carcinoma, Neuroendocrine
Hospices Civils de Lyon 122
Not applicableApproved For MarketingNCT03089658
What this trial is testing

Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)

Who this might be right for
Metastatic Merkel Cell Carcinoma
Merck KGaA, Darmstadt, Germany
Very early researchEnded earlyNCT04663126
What this trial is testing

Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma

Who this might be right for
Melanoma
John O. Prior 5
Not applicableLooking for participantsNCT05672043
What this trial is testing

Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China

Who this might be right for
MedulloblastomaCentral Nervous System Tumor, PediatricEpendymoma+3 more
Beijing Tiantan Hospital 400
Testing effectiveness (Phase 2)WithdrawnNCT02719015
What this trial is testing

Dose Escalation and Cohort Expansion of Safety and Tolerability Study of Intratumoral rAd.CD40L (ISF35) in Combination of Systemic Pembrolizumab in Patients With Refractory Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07130032
What this trial is testing

Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade

Who this might be right for
Metastatic Non-small Cell Lung Cancer (NSCLC)Metastatic Cutaneous Melanoma
EuroCityClinic LLC 90
Large-scale testing (Phase 3)Study completedNCT01974752
What this trial is testing

Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)

Who this might be right for
MetastaticUveal Melanoma
AstraZeneca 152
Not applicableStudy completedNCT01618747
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Patients With Glioblastoma Multiforme in First or Second Relapse

Who this might be right for
Glioblastoma Multiforme
Hoffmann-La Roche 20
Testing effectiveness (Phase 2)Looking for participantsNCT01906385
What this trial is testing

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Who this might be right for
Glioma
Cerenome 55
Early research (Phase 1)Study completedNCT00005633
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT03950635
What this trial is testing

Dietary Intervention in Patients with a History of Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Not applicableUnknownNCT02597335
What this trial is testing

Non Invasive Detection of IDH1/2 Mutation in Gliomas

Who this might be right for
GliomaIDH1/IDH2 Mutation
Assistance Publique - Hôpitaux de Paris 40
Next Page